This also explains why despite SOX9 being a target of the Wnt/ß-catenin pathway [1] and consequently, is highly expressed in CRC compared to adjacent healthy tissues [9], SOX9 expression level was shown not to provide prognostic values and high levels of SOX9 cannot be considered as a biomarker [29]. This evidence concerns the gene SOX9 and colorectal carcinoma.